General Hospital Of Chania Agios Georgios
- Address
- lock Available on a paid plan
General Hospital Of Chania Agios Georgios - Cardiology and Infectious Disease Research
General Hospital Of Chania Agios Georgios is a clinical research center with demonstrated expertise in both cardiovascular disease prevention and infectious disease management. The facility participates in advanced clinical trials addressing critical healthcare challenges, from life-threatening fungal infections to preventive strategies for heart failure in at-risk populations.
- Innovative treatments for candidemia and systemic fungal infections
- Heart failure prevention strategies in high-risk cardiovascular patients
- Combination therapy approaches using novel pharmaceutical agents
The center's research portfolio includes Phase III cardiovascular trials investigating heart failure prevention through combination drug therapies, as well as studies evaluating immunomodulatory approaches for candidemia, a serious bloodstream infection. This dual focus on cardiovascular risk reduction and infectious disease therapeutics positions the hospital as a comprehensive clinical research facility capable of conducting complex, multi-system disease investigations with emphasis on both treatment efficacy and patient safety outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AstraZeneca AB1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in General Hospital Of Chania Agios Georgios
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Baxdrostat and Dapagliflozin on Heart Failure Incidence and Cardiovascular Mortality in High-Risk Patients: A Phase III Randomized Controlled Trial | AstraZeneca AB | Phase III | Recruiting | May 2025 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Baxdrostat | 1 | Unknown | 2025-05-06 | 2025-05-06 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.